Patent · US Active

Broad-spectrum polypeptide against enterovirus and application thereof

US11999806B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignees

Wuhan Institute of Virology, Chinese Academy of Science · CN
FUDAN UNIVERSITY · CN

Inventors

Xi Zhou · Littleton, US
Lu Lu · San Diego, US
Yuan Fang · 安丰镇, CN
Shibo Jiang · Floral Park, US
Zezhong Liu · Shanghai, CN
Chengfeng Qin · Beijing, CN
Yang Qiu · Blacksburg, US
Jingfang Mu · 红钢城街道, CN

Key dates

Filing date	Jan 21, 2019
Grant date	Jun 4, 2024
Priority date	—
Expiry date	Jun 27, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a series of polypeptides with antiviral activity. The present invention provides a new strategy for preventing and controlling Enterovirus such as EV71, CVA16, CVA6, CVB3, and CVB5 viruses and provides a new theoretical basis for accelerating the research and development of a polypeptide small molecule drug against Enterovirus such as EV71, CVA16, CVA6, CVB3, and CVB5 viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.